Regeneron, Sanofi arthritis drug shows benefit for sickest coronavirus patients, but not for less- advanced cases
April 27, 2020 at 07:01 AM EDT
The drug, Kevzara, inhibits a pathway thought to contribute to the lung inflammation in patients with the most severe forms of Covid-19.